Company Analysis

Arcadia Biosciences, Inc. (RKDA)

Nasdaq: RKDA · Crude Petroleum & Natural Gas · Dallas, TX · filing with the SEC since 2009
Grade3.3
◀ Past 1.5● Present 3.8▶ Future 5.5
1 est.

Filings

327 filings since 2017 beside 128 insider forms · Non-accelerated filer and smaller reporting company · read from EDGAR on Nov 13, 2026
Due nextNon-accelerated filer and smaller reporting company
10-K Annual report for the fiscal year ending Dec 31, 2026Non-accelerated filers and smaller reporting companies have 90 days after the fiscal year ends. by Mar 31, 2027
10-Q Quarterly report for the quarter ending Mar 31, 2027Non-accelerated filers and smaller reporting companies have 45 days after the quarter ends; quarter ends are taken to the month end. by May 15, 2027

A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. Last time, the results release (8-K item 2.02) came 43 days after the quarter ended. The proxy statement was last filed Aug 10, 2026.

Filings a yearinsider forms included
6645504946373040
20192020202120222023202420252026

2026 counts to Nov 13, 2026.

Officer or director change (8-K item 5.02): 9 times in the last 36 months, the newest Sep 15, 2026.Listing warning from its exchange (8-K item 3.01): 2 times in the last 36 months, the newest Sep 4, 2026.Auditor change (8-K item 4.01): 1 time in the last 36 months, the newest Apr 3, 2026.SEC letters: 3 in the last 36 months, the newest Feb 5, 2026.
Insider forms 128

Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.

FiledFormWhat it is, in plain wordsPeriodAsk
Nov 12, 2026 10-Q Quarterly report Sep 30, 2026
Nov 12, 2026 8-K items 2.02, 9.01 Results released · Current report
Sep 30, 2026 SCHEDULE 13G Large holder notice
Sep 30, 2026 S-8 Employee stock plan registration
Sep 15, 2026 8-K items 5.02, 5.07, 9.01 Officer or director change; Shareholder vote · Current report Sep 10, 2026
Sep 4, 2026 8-K items 3.01, 9.01 Listing warning from its exchange · Current report Aug 31, 2026
Aug 14, 2026 SCHEDULE 13G/A Large holder update, amended
Aug 13, 2026 10-Q Quarterly report Jun 30, 2026
Aug 13, 2026 8-K items 2.02, 9.01 Results released · Current report
Aug 10, 2026 ARS Annual report to shareholders Dec 31, 2025
Aug 10, 2026 DEF 14A Proxy statement
Aug 10, 2026 8-K items 3.01, 9.01 Listing warning from its exchange · Current report Aug 4, 2026
Jul 31, 2026 PRE 14A Preliminary proxy statement Dec 31, 2025
Jul 9, 2026 424B3 Shelf offering
Jul 8, 2026 EFFECT Registration effective
Jul 2, 2026 8-K items 5.02, 5.08, 8.01 Officer or director change; item 5.08; Other event · Current report Jul 1, 2026
Jun 26, 2026 D Private placement notice
Jun 26, 2026 S-3 Shelf registration
Jun 15, 2026 8-K items 1.01, 3.02, 7.01, 9.01 Major agreement signed; Shares sold without registration; Investor disclosure (Regulation FD) · Current report Jun 11, 2026
May 15, 2026 SCHEDULE 13G Large holder notice
May 14, 2026 10-Q Quarterly report Mar 31, 2026
May 14, 2026 8-K items 2.02, 9.01 Results released · Current report
Apr 30, 2026 10-K/A Annual report, amended Dec 31, 2025
Apr 3, 2026 8-K items 4.01, 9.01 Auditor change · Current report Mar 30, 2026
Mar 26, 2026 10-K Annual report Dec 31, 2025
Mar 26, 2026 8-K items 2.02, 9.01 Results released · Current report
Feb 11, 2026 424B3 Shelf offering
Feb 10, 2026 EFFECT Registration effective
Feb 6, 2026 8-K items 5.02, 9.01 Officer or director change · Current report Feb 4, 2026
Feb 5, 2026 CORRESP Reply to the SEC
Feb 5, 2026 UPLOAD SEC comment letter
Jan 28, 2026 S-3 Shelf registration
Jan 27, 2026 D Private placement notice
Jan 27, 2026 CORRESP Reply to the SEC
Jan 20, 2026 RW Registration withdrawal request
Jan 14, 2026 8-K items 1.01, 3.02, 3.03, 7.01, 9.01 Major agreement signed; Shares sold without registration; Change to shareholders' rights; Investor disclosure (Regulation FD) · Current report Jan 9, 2026
Dec 29, 2025 425 Merger communication
Dec 29, 2025 8-K items 1.02, 7.01, 9.01 Major agreement ended; Investor disclosure (Regulation FD) · Current report Dec 24, 2025
Dec 23, 2025 8-K item 5.07 Shareholder vote · Current report Dec 19, 2025
Nov 19, 2025 ARS Annual report to shareholders Dec 31, 2024
40 of 327 shown

Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.

SI Assistanton RKDA · research, not advice